You can buy or sell Organovo and other stocks, options, ETFs, and crypto commission-free!
Organovo Holdings, Inc. engages in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. Read More The company was founded on January 30, 2012 and is headquartered in San Diego, CA.
San Diego, California
52 Week High
52 Week Low
Organovo Holdings Founder Issues Letter Regarding Alternative Paths to Illogical Merger With Tarveda Therapeutics to Stockholders
Intends to Vote "AGAINST" Proposed Merger With Tarveda Intends to vote "FOR" Reverse Stock Split and Against All Other Provisions Believes the Board, Which
— per share
Expected Apr 13, After Hours